Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |